To evaluate the role of the TFEB-p21 pathway in cancer cell survival, we performed colony formation assays using cells with different levels of TFEB and p21 (WT, TFEB KO, and HeLa cells stably overexpressing TFEB-GFP), in presence or absence of doxorubicin. This evidence concerns the gene TFEB and cancer.